Nitrocamptothecin in Treating Patients With Metastatic Melanoma

NCT00005875 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: rubitecan

Sponsor

Astex Pharmaceuticals, Inc.